Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ingrid M. P. van Rijnsoever"'
Autor:
Veroniek E. M. Harbers, Wietske Kievit, Raquel Duque Jimenez, Leo J. Schultze Kool, Ingrid M. P. van Rijnsoever, Bas H. Verhoeven, Carine J. M. van der Vleuten, D. Maroeska W. M. te Loo, Members of the Vascular Anomalies Working Group (VASCA WG) of the European Reference Network for Rare Multisystemic Vascular Diseases (VASCERN)—Project ID:
Publikováno v:
Journal of Vascular Anomalies, Vol 5, Iss 2, p e092 (2024)
Objectives:. Sirolimus is one of the first oral drugs for safe and effective treatment of patients with vascular malformations, and may save (expensive) interventions. Therefore the objective was to investigate the cost-effectiveness of sirolimus in
Externí odkaz:
https://doaj.org/article/c89fe75e4ce34841b0ee0319cd1cd153
Autor:
Veroniek E. M. Harbers, Frédérique C. M. Bouwman, Ingrid M. P. van Rijnsoever, Bas H. Verhoeven, Carine J. M. van der Vleuten, Leo J. Schultze Kool, Peter C. J. de Laat, Chantal M. A. M. van der Horst, Wietske Kievit, D. Maroeska W. M. te Loo
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionVascular malformations are rare congenital anomalies of the vascular system, which can involve the capillaries, veins, arteries, lymphatics, or a combination of vessel types. Patients with vascular malformations experience an impaired hea
Externí odkaz:
https://doaj.org/article/30adb709a8db488493df56d290cc0f8e
Autor:
Veroniek E. M. Harbers, Lilly G. J. M. Zwerink, Gerard A. Rongen, Willemijn M. Klein, Carine J. M. van der Vleuten, Ingrid M. P. van Rijnsoever, Lynda Gerdsen‐Drury, Uta E. Flucke, Bas H. Verhoeven, Peter C. J. de Laat, Chantal M. A. M. van der Horst, Leo J. Schultze Kool, D. Maroeska W. M. te Loo
Publikováno v:
Clinical and Translational Science, 16(5), 781-796. Wiley-Blackwell Publishing Ltd
Cts-Clinical and Translational Science, 16, 5, pp. 781-796
Cts-Clinical and Translational Science, 16, 781-796
Cts-Clinical and Translational Science, 16, 5, pp. 781-796
Cts-Clinical and Translational Science, 16, 781-796
Contains fulltext : 292871.pdf (Publisher’s version ) (Open Access) The clinical presentation of patients with slow-flow vascular malformations is very heterogeneous. High clinical burden and subsequent reduced health-related quality of life is som
Autor:
Harbers, Veroniek E. M.1,2 (AUTHOR), Zwerink, Lilly G. J. M.2,3 (AUTHOR), Rongen, Gerard A.4 (AUTHOR), Klein, Willemijn M.1,2 (AUTHOR), van der Vleuten, Carine J. M.2,3,5 (AUTHOR), van Rijnsoever, Ingrid M. P.2,6 (AUTHOR), Gerdsen‐Drury, Lynda1 (AUTHOR), Flucke, Uta E.2,7 (AUTHOR), Verhoeven, Bas H.2,8 (AUTHOR), de Laat, Peter C. J.9 (AUTHOR), van der Horst, Chantal M. A. M.10 (AUTHOR), Schultze Kool, Leo J.1,2,5 (AUTHOR), te Loo, D. Maroeska W. M.2,11 (AUTHOR) maroeska.teloo@radboudumc.nl
Publikováno v:
CTS: Clinical & Translational Science. May2023, Vol. 16 Issue 5, p781-796. 16p.
Publikováno v:
Drug Week; 5/3/2024, p2052-2052, 1p
Publikováno v:
Clinical Trials Week; 5/8/2023, p734-734, 1p